Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adverse Events
100%
Patient-reported Outcomes
100%
Cancer Therapy
100%
Event Identification
100%
Patient-Reported Outcomes Measurement Information System (PROMIS)
62%
Common Terminology Criteria for Adverse Events (CTCAE)
37%
Patient Interview
25%
Systematic Method
25%
Summary Information
25%
Randomized Controlled Trial
12%
Patient Demographics
12%
Population-based
12%
Patient Files
12%
Oncologic
12%
Prostate Cancer Patients
12%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
12%
Cancer Treatment
12%
Oncologists
12%
Specific Patient
12%
Cancer Population
12%
Drug Approval
12%
View-specific
12%
Randomized Phase III Trial
12%
Oncological Treatment
12%
Routine Treatment
12%
Purposive Sampling
12%
Item Selection
12%
Cytostatic Drugs
12%
Electronic Patient File
12%
Symptomatic Adverse Events
12%
3-phase
12%
Write-in
12%
Timely Monitoring
12%
Nursing and Health Professions
Adverse Event
100%
Patient-Reported Outcome
100%
Cancer Therapy
100%
Symptom
20%
Clinical Audit
20%
Food and Drug Administration
20%
Patient Population
10%
Malignant Neoplasm
10%
Prostate Cancer
10%
Oncologist
10%
Nomenclature
10%
Cytostatic Agent
10%
Drug Approval
10%
Medicine and Dentistry
Adverse Event
100%
Cancer Therapy
100%
Patient-Reported Outcome
100%
Symptom
20%
Randomized Controlled Trial
20%
Patient Population
10%
Malignant Neoplasm
10%
Prostate Cancer
10%
Cytostatic Agent
10%
Oncologist
10%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Adverse Event
100%
Symptom
20%
Randomized Controlled Trial
20%
Prostate Cancer
10%
Cytostatic Agent
10%
Drug Approval
10%